Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report
JCO Precision Oncology · 2023-01 · (7)
DOI: 10.1200/po.22.00528 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCO Precision Oncology, 2023-01. Verfasst von Wen-Kuan Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine,…. Hauptthemen laut MEDLINE: Sarcoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
- Department of Anatomic Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
- Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Taipei, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
- Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
- Department of Surgery and GIST Team, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
ORCID-Profile: Wen-Kuan Huang, Shih-Chiang Huang, Po-Hung Lin, Chiao-En Wu, Cheng-Keng Chuang
Zitieren
APA
Huang, W. K., Huang, S. C., Chen, C. M., Lin, P. H., Wu, C. E., Chuang, C. K., & Yeh, C. N. (2023). Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report. JCO Precision Oncology. https://doi.org/10.1200/po.22.00528
Vancouver
Huang WK, Huang SC, Chen CM, Lin PH, Wu CE, Chuang CK, et al. Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report. JCO Precision Oncology. 2023. doi:10.1200/po.22.00528
BibTeX
@article{Huang2023,
author = {Huang, Wen-Kuan and Huang, Shih-Chiang and Chen, Chien-Ming and Lin, Po-Hung and Wu, Chiao-En and Chuang, Cheng-Keng and Yeh, Chun-Nan},
title = {Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report},
journal = {JCO Precision Oncology},
year = {2023},
number = {7},
doi = {10.1200/po.22.00528}
}
EUVIMED